Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Pathogenesis and treatment of renal failure in multiple myeloma.

Dimopoulos MA, Kastritis E, Rosinol L, Bladé J, Ludwig H.

Leukemia. 2008 Aug;22(8):1485-93. doi: 10.1038/leu.2008.131. Epub 2008 Jun 5. Review.

PMID:
18528426
2.

Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America.

Weber DM, Chen C, Niesvizky R, Wang M, Belch A, Stadtmauer EA, Siegel D, Borrello I, Rajkumar SV, Chanan-Khan AA, Lonial S, Yu Z, Patin J, Olesnyckyj M, Zeldis JB, Knight RD; Multiple Myeloma (009) Study Investigators.

N Engl J Med. 2007 Nov 22;357(21):2133-42.

3.

Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma.

Dimopoulos M, Spencer A, Attal M, Prince HM, Harousseau JL, Dmoszynska A, San Miguel J, Hellmann A, Facon T, Foà R, Corso A, Masliak Z, Olesnyckyj M, Yu Z, Patin J, Zeldis JB, Knight RD; Multiple Myeloma (010) Study Investigators.

N Engl J Med. 2007 Nov 22;357(21):2123-32. Erratum in: N Engl J Med. 2009 Jul 30;361(5):544.

4.

Pharmacokinetics of lenalidomide in subjects with various degrees of renal impairment and in subjects on hemodialysis.

Chen N, Lau H, Kong L, Kumar G, Zeldis JB, Knight R, Laskin OL.

J Clin Pharmacol. 2007 Dec;47(12):1466-75. Epub 2007 Oct 22.

PMID:
17954615
5.

Reversibility of renal failure in newly diagnosed multiple myeloma patients treated with high dose dexamethasone-containing regimens and the impact of novel agents.

Kastritis E, Anagnostopoulos A, Roussou M, Gika D, Matsouka C, Barmparousi D, Grapsa I, Psimenou E, Bamias A, Dimopoulos MA.

Haematologica. 2007 Apr;92(4):546-9.

6.

Renal failure in multiple myeloma: incidence, correlations, and prognostic significance.

Eleutherakis-Papaiakovou V, Bamias A, Gika D, Simeonidis A, Pouli A, Anagnostopoulos A, Michali E, Economopoulos T, Zervas K, Dimopoulos MA; Greek Myeloma Study Group.

Leuk Lymphoma. 2007 Feb;48(2):337-41.

PMID:
17325894
7.

Multiple myeloma.

Korbet SM, Schwartz MM.

J Am Soc Nephrol. 2006 Sep;17(9):2533-45. Epub 2006 Aug 2. Review. No abstract available.

8.
9.

International uniform response criteria for multiple myeloma.

Durie BG, Harousseau JL, Miguel JS, Bladé J, Barlogie B, Anderson K, Gertz M, Dimopoulos M, Westin J, Sonneveld P, Ludwig H, Gahrton G, Beksac M, Crowley J, Belch A, Boccadaro M, Cavo M, Turesson I, Joshua D, Vesole D, Kyle R, Alexanian R, Tricot G, Attal M, Merlini G, Powles R, Richardson P, Shimizu K, Tosi P, Morgan G, Rajkumar SV; International Myeloma Working Group.

Leukemia. 2006 Sep;20(9):1467-73. Epub 2006 Jul 20. Erratum in: Leukemia. 2007 May;21(5):1134. Leukemia. 2006 Dec;20(12):2220.

PMID:
16855634
10.

Clinical review: specific aspects of acute renal failure in cancer patients.

Darmon M, Ciroldi M, Thiery G, Schlemmer B, Azoulay E.

Crit Care. 2006;10(2):211. Review.

11.

Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United kingdom Medical Research Council trials between 1980 and 2002--Medical Research Council Adult Leukaemia Working Party.

Augustson BM, Begum G, Dunn JA, Barth NJ, Davies F, Morgan G, Behrens J, Smith A, Child JA, Drayson MT.

J Clin Oncol. 2005 Dec 20;23(36):9219-26. Epub 2005 Nov 7.

PMID:
16275935
12.

Renal, hematologic and infectious complications in multiple myeloma.

Bladé J, Rosiñol L.

Best Pract Res Clin Haematol. 2005;18(4):635-52. Review.

PMID:
16026742
13.
14.

Renal pathologic spectrum in an autopsy series of patients with plasma cell dyscrasia.

Herrera GA, Joseph L, Gu X, Hough A, Barlogie B.

Arch Pathol Lab Med. 2004 Aug;128(8):875-9. Review.

PMID:
15270616
15.

Renal failure in multiple myeloma: reversibility and impact on the prognosis. Nordic Myeloma Study Group.

Knudsen LM, Hjorth M, Hippe E.

Eur J Haematol. 2000 Sep;65(3):175-81.

PMID:
11007053
16.

Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients from a single institution.

Bladé J, Fernández-Llama P, Bosch F, Montolíu J, Lens XM, Montoto S, Cases A, Darnell A, Rozman C, Montserrat E.

Arch Intern Med. 1998 Sep 28;158(17):1889-93.

PMID:
9759684
17.

Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant.

Bladé J, Samson D, Reece D, Apperley J, Björkstrand B, Gahrton G, Gertz M, Giralt S, Jagannath S, Vesole D.

Br J Haematol. 1998 Sep;102(5):1115-23. No abstract available.

PMID:
9753033
18.

Renal function in newly diagnosed multiple myeloma--a demographic study of 1353 patients. The Nordic Myeloma Study Group.

Knudsen LM, Hippe E, Hjorth M, Holmberg E, Westin J.

Eur J Haematol. 1994 Oct;53(4):207-12.

PMID:
7957804

Supplemental Content

Support Center